首页> 美国卫生研究院文献>other >Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines
【2h】

Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

机译:鉴定和表征在人原发性肺癌细胞株肿瘤干细胞特性的细胞的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung cancer (LC) with its different subtypes is generally known as a therapy resistant cancer with the highest morbidity rate worldwide. Therapy resistance of a tumor is thought to be related to cancer stem cells (CSCs) within the tumors. There have been indications that the lung cancer is propagated and maintained by a small population of CSCs. To study this question we established a panel of 15 primary lung cancer cell lines (PLCCLs) from 20 fresh primary tumors using a robust serum-free culture system. We subsequently focused on identification of lung CSCs by studying these cell lines derived from 4 representative lung cancer subtypes such as small cell lung cancer (SCLC), large cell carcinoma (LCC), squamous cell carcinoma (SCC) and adenocarcinoma (AC). We identified a small population of cells strongly positive for CD44 (CD44high) and a main population which was either weakly positive or negative for CD44 (CD44low/−). Co-expression of CD90 further narrowed down the putative stem cell population in PLCCLs from SCLC and LCC as spheroid-forming cells were mainly found within the CD44highCD90+ sub-population. Moreover, these CD44highCD90+ cells revealed mesenchymal morphology, increased expression of mesenchymal markers N-Cadherin and Vimentin, increased mRNA levels of the embryonic stem cell related genes Nanog and Oct4 and increased resistance to irradiation compared to other sub-populations studied, suggesting the CD44highCD90+ population a good candidate for the lung CSCs. Both CD44highCD90+ and CD44highCD90 cells in the PLCCL derived from SCC formed spheroids, whereas the CD44low/− cells were lacking this potential. These results indicate that CD44highCD90+ sub-population may represent CSCs in SCLC and LCC, whereas in SCC lung cancer subtype, CSC potentials were found within the CD44high sub-population.
机译:具有不同亚型的肺癌(LC)通常被认为是全球耐药性最高的发病率。肿瘤的治疗抗性被认为与肿瘤内的癌症干细胞(CSC)有关。有迹象表明,肺癌是由少量的CSC繁殖和维持的。为了研究这个问题,我们使用强大的无血清培养系统从20种新鲜的原发肿瘤中建立了15种原发性肺癌细胞系(PLCCL)。随后,我们通过研究这些源自4种代表性肺癌亚型的细胞系(如小细胞肺癌(SCLC),大细胞癌(LCC),鳞状细胞癌(SCC)和腺癌(AC))来专注于肺CSC的鉴定。我们鉴定出一小群对CD44呈强阳性的细胞(CD44 high )和一主要对CD44呈弱阳性或阴性的细胞(CD44 low /-)。 CD90的共表达进一步缩小了来自SCLC和LCC的PLCCLs中假定的干细胞种群,因为形成球形的细胞主要存在于CD44 high CD90 + 子种群中。此外,这些CD44 high CD90 + 细胞显示了间充质形态,增加了间充质标记N-钙黏着蛋白和波形蛋白的表达,增加了胚胎干细胞相关基因Nanog和Oct4的mRNA水平。与其他研究的亚群相比,其对辐射的抵抗力增强,表明CD44 CD90 + 人群是肺CSCs的良好候选者。来自SCC的PLCCL中的CD44 high CD90 + 和CD44 high CD90 -细胞均形成球体,而CD44 low /-细胞缺乏这种潜力。这些结果表明,CD44 CD90 + 亚群可能代表SCLC和LCC中的CSC,而在SCC肺癌亚型中,CD44 中发现了CSC电位高子人口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号